金域医学(603882) - 2018 Q1 - 季度财报

Financial Performance - Operating revenue for the period was CNY 918,494,689.69, representing a year-on-year growth of 14.62%[6] - Net profit attributable to shareholders was CNY 9,426,897.04, an increase of 33.30% compared to the same period last year[6] - The net profit for the first quarter of 2018 was RMB 10,183,874.76, representing a 74.71% increase compared to RMB 5,829,058.02 in the previous period[15] - The company reported a total comprehensive income of ¥9,670,592.11, compared to ¥5,772,362.42 in the previous period, marking a growth of 77.5%[28] - The total profit for the current period was ¥246,286,477.65, compared to a loss of ¥2,808,243.57 in the previous period, indicating a significant turnaround[31] Cash Flow - The net cash flow from operating activities improved to -CNY 39,775,753.79, a 12.14% reduction in losses compared to the previous year[6] - The net cash flow from operating activities was -39,775,753.79, an improvement from -45,271,636.67 in the previous period, indicating a reduction in cash outflow[35] - Total cash inflow from operating activities was 835,363,463.25, compared to 704,659,609.30 in the previous period, reflecting a year-over-year increase of approximately 18.5%[35] - Cash outflow from operating activities totaled 875,139,217.04, up from 749,931,245.97, representing an increase of about 16.7%[35] - The net cash flow from investing activities was -69,578,285.91, worsening from -54,314,251.99 in the previous period[35] - The net cash flow from financing activities was -13,736,111.62, compared to -10,226,767.27 in the previous period, showing a decline in cash flow[36] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 3,326,566,097.48, a slight increase of 0.16% compared to the end of the previous year[6] - Current assets decreased to CNY 1,873,708,156.52 from CNY 1,901,473,266.41, a decline of 1.46%[18] - Total liabilities increased to CNY 1,590,555,796.96 from CNY 1,577,031,755.70, an increase of 0.15%[20] - Total equity decreased to CNY 1,736,010,300.52 from CNY 1,744,093,786.35, a decline of 0.46%[20] - Non-current assets totaled CNY 1,452,857,940.96, up from CNY 1,419,652,275.64, indicating an increase of 2.67%[19] Shareholder Information - The number of shareholders at the end of the reporting period was 27,895[10] - The largest shareholder, Liang Yaoming, held 15.52% of the shares, totaling 71,068,209 shares[10] Earnings and Expenses - Basic and diluted earnings per share remained at CNY 0.02, unchanged from the previous year[6] - Management expenses rose to ¥13,325,288.12 from ¥6,931,762.37, indicating an increase of 92.5%[29] - The company reported a net profit of CNY 10,526,159.85 from non-recurring gains and losses[9] - The net profit after deducting non-recurring gains and losses was -CNY 1,099,262.81, showing a significant improvement of 64.34% year-on-year[6] Other Financial Metrics - The weighted average return on equity decreased to 0.55%, down by 0.09 percentage points from the previous year[6] - The company experienced a 1253.88% increase in the impact of exchange rate changes on cash and cash equivalents, resulting in a negative effect of RMB 915,968.65[15] - The company’s operating income growth led to a 43.42% increase in taxes and surcharges, totaling RMB 1,392,712.51[14] - Other income surged by 1973.42% to RMB 13,710,104.02, primarily due to the implementation of new accounting policies[14]